Ps. Devamanoharan et al., Non-enzymatic glycation of lens proteins and haemoglobin-inhibition by pyruvate: an in-vivo study, DIABET OB M, 1(3), 1999, pp. 159-164
Aim: Previous studies have demonstrated that pyruvate can prevent protein g
lycation and oxidative stress under in-vitro conditions. The aim of this st
udy was to examine the in-vivo effectiveness of this metabolite against gly
cation of lens crystallins and haemoglobin in galactosemic rats.
Methods: Sprague-Dawley rats were maintained on a 30% or 50% galactose-cont
aining diet in the absence or presence of 2% or 5% pyruvate in food and wat
er, respectively. The animals were killed subsequently and the extent of gl
ycation of lens crystallins and haemoglobin was determined using an affinit
y column chromatograpic technique.
Results: Maintenance of rats on the high galactose diet resulted in a signi
ficant increase in glycation of both the proteins. The increase was faster
and more substantial in the animals maintained on the 50% galactose diet th
an that in the animals fed a 30% galactose diet. The increase in the latter
was also very significant. Supplementation with pyruvate inhibited the pro
cess.
Conclusion: The inhibition is attributable to a competitive binding of pyru
vate to the protein NH2 groups as well as to the antioxidant effect of the
compound. The studies therefore suggest that this and other alpha-keto-acid
s may be physiologically useful in minimizing glycation and oxidative stres
s induced tissue pathology by the hyperglycaemic conditions, such as diabet
es and galactosemia. The results are also considered pharmacologically sign
ificant.